Jeff Yass’s Scribe Therapeutics SCTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SCTX
BBA
Jeff Yass's SCTX Position: Q3 2026 in Review
Jeff Yass opened a new position in Scribe Therapeutics (SCTX) in Q3 2026: 13,641 shares worth $251K. The stake represents ﹤0.01% of the portfolio and ranks #11387 among its holdings.
62 funds tracked by Wall St. Rank hold SCTX as of Q3 2026.
- Jeff Yass held 13,641 shares of Scribe Therapeutics worth $251K as of Q3 2026.
- Scribe Therapeutics was a new Jeff Yass position in Q3 2026.
- Scribe Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11387 holding.
- 62 funds tracked by Wall St. Rank held Scribe Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.